logo

Loading..
Svenska
  • Home
  • About us
    About us
      • About BioArctic
      • CEO Gunilla Osswald presents BioArctic
      • Vision, mission and business concept
      • Culture and values
      • Objective and strategy
      • Collaborations and partners
      • Sustainability
        • Code of Conduct
        • Work environment
        • Diversity
      • Organization
        • Board of directors
        • Senior management
        • Senior scientific advisors
        • Scientific advisory boards
      • History
  • Research and development
    Research and development
      • Technology
      • Project portfolio
      • Focus Areas
        • Alzheimer´s disease
        • Parkinson’s disease
        • Other CNS disorders
        • Blood-brain barrier technology
        • Diagnostics
  • Governance
    Governance
      • Governance structure
      • Corporate Governance Reports
      • General Meeting
        • General Meetings
      • Nomination Committee
        • Nomination Committees
      • Board of Directors
        • Board Committees
        • Work of the Board of Directors
      • Senior management
      • Remuneration
      • Internal audit and control
      • Audit
      • Articles of Association
  • Investors
    Investors
      • The share
        • Share capital development
        • Dividend
        • Ownership structure
        • Analysts
      • Financial reports
      • Prospectus
      • Presentations
      • Press releases
      • News
      • Calendar
      • Privacy policy - Shareholders
      • Subscribe
      • Contact
  • Media
    Media
      • Press releases
      • News
      • Image bank
      • Subscribe
      • Contacts
  • Career
    Career
      • Career
      • Job openings
      • Open application
  • Contacts
    Contacts
      • Office
      • Investors
      • Media
Svenska
June 10, 2019

Redeye Growth Day Presentation and Interview with EFN

Gunilla Osswald, CEO, presented BioArctic at the Redeye Growth Day in Stockholm, Sweden.

Video (in Swedish)

EFN Interview (in Swedish)

https://www.efn.se/bors-finans/biorctic-ser-framgangar-inom-samtliga-omraden/

Calendar

  • July 12, 2022Interim report January – June 2022
  • October 20, 2022Interim report January – September 2022
  • February 3, 2023Full Year Report January – December 2022
More events

Subscribe

Read more about how we protect your personal data.
  • Investors
    • The share
      • Share capital development
      • Dividend
      • Ownership structure
      • Analysts
    • Financial reports
    • Prospectus
    • Presentations
    • Press releases
    • News
    • Calendar
    • Privacy policy – Shareholders
    • Subscribe
    • Contact
Oskar Bosson
Oskar Bosson
Vice President Communications & IR
oskar.bosson@bioarctic.se
+46704107180
About us
  • About BioArctic
  • CEO Gunilla Osswald presents BioArctic
  • Vision, mission and business concept
  • Culture and values
  • Objective and strategy
  • Collaborations and partners
  • Sustainability
  • Organization
  • History
Research and development
  • Technology
  • Project portfolio
  • Focus Areas
Governance
  • Governance structure
  • Corporate Governance Reports
  • General Meeting
  • Nomination Committee
  • Board of Directors
  • Senior management
  • Remuneration
  • Internal control
  • Audit
  • Articles of Association
Investors
  • The share
  • Financial reports
  • Prospectus
  • Presentations
  • Press releases
  • News
  • Calendar
  • Privacy policy – Shareholders
  • Subscribe
  • Contact
Media
  • Press releases
  • News
  • Image bank
  • Subscribe
  • Contacts
Career
  • Career
  • Job openings
  • Open application
Contacts
  • Office
  • Investors
  • Media

BioArctic AB, Warfvinges väg 35, SE-112 51 Stockholm, Sweden. Phone: +46 8 695 69 30. E-mail: info@bioarctic.se. Registration number: 556601-2679.

© 2022 BioArctic AB – All rights reserved

  • About Cookies
  • Processing of personal data